The acute effect of the antioxidant drug “U-74389G†on mean corpuscular volume levels during hypoxia reoxygenation injury in rats
Abstract
Background: This experimental study examined the effect of the antioxidant drug “U-74389Gâ€, on a rat model and particularly in a hypoxia – reoxygenation (HR) protocol. The effects of that molecule were studied hematologically using mean blood corpuscular volume (MCV) levels.
Methods: 40 rats of mean weight 231.875 g were used in the study. MCV levels were measured at 60 min of reoxygenation (groups A and C) and at 120 min of reoxygenation (groups B and D) with administration of the drug U-74389G in groups C and D.
Results: U-74389G administration significantly increased the predicted MCV levels by 2.88%+0.69 (p= 0.0002). Reoxygenation time non-significantly increased the MCV levels by 0.57%+0.83% (p=0.4103). However, U-74389G administration and reoxygenation time together significantly increased the MCV levels by 1.60%+0.43% (p= 0.0005).
Conclusions: U-74389G administration whether it interacted or not with reoxygenation time has significant increasing short – term effect on recovery pathophysiology of MCV values.
Downloads
References
https://www.caymanchem.com/app/template/Product.vm/catalog/75860.
Fenglin Shi, Jennifer Cavitt, Kenneth L Audus. 21-aminosteroid and 2-(aminomethyl)chromans inhibition of arachidonic acid-induced lipid peroxidation and permeability enhancement in bovine brain microvessel endothelial cell monolayers. Free Radical Biology and Medicine, 19(3), 349-357 (1995).
Tsompos C, Panoulis C, Toutouzas K, Triantafyllou A, Zografos G, Papalois A. The effect of the antioxidant drug “U-74389G†on γ-glutamyltransferase levels during ischemia reperfusion injury in rats. Literati Journal of Pharmaceutical Drug Delivery Technologies, 2016;2(2):8-12.
Tsompos C, Panoulis C, Toutouzas K, Triantafyllou A, Zografos G, Papalois A. The antioxidant drug“U-74389G†attenuates the mean corpuscular hemoglobin concentration levels during hypoxia reoxygenation injury in rats. JIRMEPS 2016; 9(4): 158-163.
Τsompos C., Panoulis C., Τοutouzas K., Ζografos G., Papalois A. The Effect of the Antioxidant Drug “U-74389G†on Creatinine Levels during Ischemia Reperfusion Injury in Rats. Curr Urol 2015;9(2):73-78.
Τsompos C., Panoulis C., Τοutouzas K., Triantafyllou A., Ζografos G., Papalois A. The Effect of the Antioxidant Drug “U-74389G†on Uric acid Levels during Ischemia Reperfusion Injury in Rats. Ser J Exp Clin Res 2016; 17 (2): 1-1.
Yildiz H, DurmuÅŸ AS, ÅžimÅŸek H, et al. Effects of sildenafil citrate on torsion/detorsion-induced changes in red blood cell and plasma lipid peroxidation, antioxidants, and blood hematology of male rats. Eur J Obstet Gynecol Reprod Biol. 2011 Dec;159(2):359-63.
Nemeth N, Lesznyak T, Szokoly M, et al. Allopurinol prevents erythrocyte deformability impairing but not the hematological alterations after limb ischemia-reperfusion in rats. J Invest Surg. 2006 Jan-Feb;19(1):47-56.
Berra HH, Piaggio E, Revelli SS, et al. Blood viscosity changes in experimentally Trypanosoma cruzi-infected rats. Clin Hemorheol Microcirc. 2005;32(3):175-82.
Putintsev VI, Iartseva SV. Characteristics of hemorheological processes in patients with chronic obstructive bronchitis combined with ischemic heart disease. Lik Sprava. 2004 Dec;(8):23-7.
Mueller T, Luft C, Haidinger D, et al. Erythrocyte mean corpuscular volume associated with the anatomical distribution in peripheral arterial disease. Vasa. 2002 May;31(2):81-5.
Wilke A, Kruse T, Maisch B. Angina pectoris in leiomyoma. Herz. 1998 Aug;23(5):299-302.
Penix LP. Ischemic strokes secondary to vitamin B12 deficiency-induced hyperhomocystinemia. Neurology. 1998 Aug;51(2):622-4.
Donaldson GC, Robinson D, Allaway SL. An analysis of arterial disease mortality and BUPA health screening data in men, in relation to outdoor temperature. Clin Sci (Lond). 1997 Mar;92(3):261-8.
Chen YM, Ruan M, Wang YQ, et al. Analysis of clinical characteristics in 45 cases of Diamond-Blackfan anemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Jun;20(3):646-10.
Copyright (c) 2016 Research Journal of Pharmacology and Toxicology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
A) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
B) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
C) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
D) Author agree to submit Copyright form after accepetance of article.